Taken together, RBFOX3 inhibits the malignant phenotype of NSCLC cells by increasing circIGF1R biogenesis through binding with the IGF1R pre-mRNA, which inhibits IGF1R mRNA synthesis. The gene discussed is IGF1R; the disease is non-small cell lung carcinoma.